Visionary Wealth Advisors purchased a new position in Novo Nordisk A/S (NYSE:NVO – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,294 shares of the company’s stock, valued at approximately $209,000. Several other institutional investors and hedge funds have also […]